The ACIP now recommends all adults 19-59 and adults >59 with risk factors be vaccinated for Hep B.

There are currently four approved adult Hep B vaccines on the market:

  • GSK Engerix-B
  • Merck Recombivax HB
  • Dynavax Heplisav-B
  • VBI Vaccines PreHevbrio

To read more about the April 2022 ACIP recommendations, please click here.